Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
Wednesday, February 08, 2023
Syneos Health® announced a strategic partnership with Haystack Health to improve the identification and enrolment of patients for clinical trials.
The combination of Syneos Health with Haystack Health will more effectively and efficiently identify and match clinical trial opportunities for patients. For sponsors and sites, this partnership will deliver valuable research tools and workflow efficiencies resulting in improved timelines and increased patient recruitment. Initially, the new data solutions will only be available for Syneos Health sites in the US, with a focus on oncology and immunology. Later this year, the partnership plans to expand to include additional therapeutic areas and sites across the globe.
The challenges of enrolling patients in clinical trials are well documented. Protocol complexity and specificity in precision medicine are making patient recruitment even more difficult. Haystack Health offers an advanced solution leveraging AI to match patients to trials while preserving privacy.
The companies’ combined capabilities help improve recruitment strategy to focus on patients who are less likely to fail trial screeners, reducing the burden on patients, trials and sites.
